Mettrum Announces Second Quarter 2017 Financial Results Notification

Mettrum Announces Second Quarter 2017 Financial Results Notification

ID: 504547

(firmenpresse) - TORONTO, ONTARIO -- (Marketwired) -- 11/02/16 -- Mettrum Health Corp. ("Mettrum" or the "Company") (TSX VENTURE: MT), a vertically integrated provider of cannabis products, is pleased to announce that it will report its second quarter 2017 financial results for the period ended September 30, 2016, on November 15, 2016 after the close of market.

About Mettrum Health Corp.

Mettrum Health Corp. is a Tier 1 Industry Issuer listed on TSX Venture Exchange. Mettrum Ltd., a wholly owned subsidiary of the Company, is a Toronto-based company and a licensed producer of medical cannabis under the Access to Cannabis for Medical Purposes Regulations (Canada) issued pursuant to the Controlled Drugs and Substances Act (Canada) (the "ACMPR"), which came into effect on August 24th, 2016. Mettrum received its first license from Health Canada under the Marihuana for Medical Purposes Regulations (the "MMPR") on November 1, 2013 and began production of medical cannabis at its first production facility in Bowmanville, Ontario. Mettrum received its second license from Health Canada under the MMPR on December 11, 2014 for its other wholly-owned subsidiary, Agripharm Corp., at Mettrum Creemore facility in Clearview, Ontario. Mettrum received its third license from Health Canada under the MMPR on December 17, 2015 for Mettrum Ltd. at its new 60,000 square foot production and distribution facility in Bowmanville, Ontario. Mettrum is a leading producer and vendor of medical cannabis under the ACMPR system. In addition, through its wholly-owned subsidiary Mettrum Hempworks, Mettrum also is a licensed producer and distribution of industrial cannabis (hemp) products, including Mettrum's functional food line, Mettrum Originals™, under the Industrial Hemp Regulations (Canada) issued pursuant to the Controlled Drugs and Substances Act (Canada).

Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this Press release.







Contacts:
Ali Mahdavi
Director, Investor Relations
416.962.3300

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Medovex Corporation Announces Successful Largest Living Tissue Population Test to Date Medovex Corporation Conducts Successful Cadaver Lab at NASS 2016
Bereitgestellt von Benutzer: Marketwired
Datum: 02.11.2016 - 20:00 Uhr
Sprache: Deutsch
News-ID 504547
Anzahl Zeichen: 0

contact information:
Town:

TORONTO, ONTARIO



Kategorie:

Alternative



Diese Pressemitteilung wurde bisher 197 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Mettrum Announces Second Quarter 2017 Financial Results Notification"
steht unter der journalistisch-redaktionellen Verantwortung von

Mettrum Health Corp. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Mettrum Health Corp.



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z